Quest Diagnostics
DGX
#1095
Rank
โ‚น1.833 T
Marketcap
โ‚น16,396
Share price
-0.91%
Change (1 day)
23.90%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น776.19. In 2024 the company made an earnings per share (EPS) of โ‚น698.93 an increase over its 2023 EPS that were of โ‚น681.86.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.046.88%
2024โ‚น698.932.5%
2023โ‚น681.86-5.83%
2022โ‚น724.08-49.21%
2021โ‚น1,42649.72%
2020โ‚น952.2766.67%
2019โ‚น571.3618%
2018โ‚น484.22-4.26%
2017โ‚น505.7823.19%
2016โ‚น410.55-7.11%
2015โ‚น442.0028.46%
2014โ‚น344.07-31.61%
2013โ‚น503.0860.46%
2012โ‚น313.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น920.82 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น63.94-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.06-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น18.87-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น167.88-78.37%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands